-
Allos Therapeutics Inc. et al v. Fresenius Kabi USA, LLC DC
- 1:14-cv-00778
- D. Del.
- Judge: Richard G. Andrews
- Filed: 06/19/2014
- Closed: 08/17/2016
- Latest Docket Entry: 08/17/2016
- PACER
- Docket updated daily
4
Plaintiffs
5
Defendants
1
Accused
Product
3
Patents-in-Suit
791
Days in
Litigation
-
Allos Therapeutics Inc. et al v. Fresenius Kabi USA, LLC DC
- 1:14-cv-00778
- D. Del.
- Judge: Richard G. Andrews
- Filed: 06/19/2014
- Closed: 08/17/2016
- Latest Docket Entry: 08/17/2016
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Dr. Reddy's Lab., Inc.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 6,028,071 A | All Asserted Claims |
Infringement
Entry 149
|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 7,622,470 B2 | All Asserted Claims |
Infringement
Entry 149
|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 8,299,078 B2 | All Asserted Claims |
Infringement
Entry 149
|
Dr. Reddy's Laboratories Ltd.
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 6,028,071 A | All Asserted Claims |
Infringement
Entry 149
|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 7,622,470 B2 | All Asserted Claims |
Infringement
Entry 149
|
| Generic 20 mg/1 mL vial, 40 mg/2 mL vial pralatrexate injection solutions pursuant to ANDA No. 206183 | US 8,299,078 B2 | All Asserted Claims |
Infringement
Entry 149
|
